FibroGen, Inc. (NASDAQ: FGEN) Grants Eluminex Biosciences Exclusively Licensed Global Rights...

0
Corneal blindness is pervasive in China, with more than 100,000 cases being reported every year. The available treatments include corneal tissue harvested from genetically...

9 Meters Biopharma, Inc. (NASDAQ: NMTR) Broadens its Existing Pipeline with...

0
9 Meters Biopharma, Inc. (NASDAQ: NMTR) has a history of bringing novel therapeutics to the market. The entity, which owns all global rights to...

Popular News

Jaguar Health Inc. (NASDAQ:JAGX) Announces Development and commercialization Plan for Crofelemer...

0
Jaguar Health Inc. (NASDAQ:JAGX) and its wholly-owned subsidiary, Napo Pharmaceuticals Inc., have announced a development and commercialization plan for crofelemer. Crofelemer is the company's...

MAKE IT MODERN

LATEST REVIEWS

Halozyme Therapeutics Inc. (NASDAQ:HALO) Reports Strong Q3 With Revenue Of $65.3...

0
Halozyme Therapeutics Inc. (NASDAQ:HALO) has announced Q3 financial results in which revenue was $65.3 million and EPS of $0.25 and also provided an updated...

MAKE IT MODERN

PERFORMANCE TRAINING

Catalyst Biosciences Inc. (NASDAQ:CBIO) Presents Encouraging Phase 2b Results For Subcutaneous DalcA In Haemophilia...

0
Catalyst Biosciences Inc. (NASDAQ:CBIO)  has announced safety and efficacy results from its Phase 2b study of subcutaneously administered Dalcinonacog Alfa (DalcA). Catalyst presented DalcA study...

The Bull Opportunity Ahead in Telehealth Stocks (TDOC, ONEM, ISWH, AMWL)

0
Few trends are as easily identifiable as the structural opportunity in the telehealth space. We have undergone a transformative experience as a...

Ampio Pharmaceutical Inc. (NYSEAMERICAN:AMPE) Advance Inhaled Ampion Study To Third Group Of COVID-19 Patients

0
Ampio Pharmaceutical Inc. (NYSEAMERICAN:AMPE) has announced that the third group in its Phase 1 inhaled Ampion™ clinical trial is receiving treatment after clearance by...

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Enters Commercialization Agreement with Otsuka Pharmaceuticals for Voclosporin

0
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) has announced the signing of a collaboration and license agreement with Otsuka Pharmaceutical Co. Ltd. The agreement is...

Acasti Pharma Inc (NASDAQ:ACST) Receives The FDA’s Written Response Regarding Request For Type C...

0
Acasti Pharma Inc (NASDAQ:ACST) has announced that the Food and Drug Administration (FDA) responded to its request for a TRILOGY 1 Briefing Package, as...

MAKE IT MODERN

POPULAR

[/tdc_zone]

.td-post-views{ display: none !important; }